1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Pharmaceutical Analysis & Statistics (p2)

Global Pharmaceutical Analysis & Statistics (p2)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • ICON Group

All regions

31-60 of about 200 reports

The 2021-2026 World Outlook for Central Nervous System (CNS) Therapeutics

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for central nervous system (CNS) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Erectile Dysfunction Therapeutics

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for erectile dysfunction therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • November 2019
  • 309 pages

This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Irritable Bowel Syndrome (IBS) Therapeutics

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for irritable bowel syndrome (IBS) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Generic Antiviral Drugs

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for generic antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Antiviral
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Children’s Vitamins and Dietary Supplements

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for children’s vitamins and dietary supplements across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Dietary Supplement
  • OTC
  • World
  • Demand

The 2021-2026 World Outlook for Antiviral Drugs

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ...

  • Antiviral
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Acute Myeloid Leukemia (AML) Therapeutics

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for acute myeloid leukemia (AML) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Systemic Broad- and Medium-Spectrum Antibiotic Cephalosporins

  • $ 995
  • November 2019
  • 315 pages

This study covers the world outlook for systemic broad- and medium-spectrum antibiotic cephalosporins across more than 190 countries. For each year reported, estimates are given for the latent demand, ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Nanotechnology Drug Delivery Systems

  • $ 995
  • November 2019
  • 301 pages

This study covers the world outlook for nanotechnology drug delivery systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Drug Delivery
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Testosterone Replacement Therapies (TRT)

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for testosterone replacement therapies (TRT) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Acute Heart Failure (AHF) Therapeutics

  • $ 995
  • November 2019
  • 301 pages

This study covers the world outlook for acute heart failure (AHF) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Biological Drugs

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for biological drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

  • Biopharmaceutical
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Needle-Free Injection Devices

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for needle-free injection devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Drug Delivery
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Systemic Broad- and Medium-Spectrum Antibiotic Tetracyclines, Chlortetracycline, and Congeners

  • $ 995
  • November 2019
  • 318 pages

This study covers the world outlook for systemic broad- and medium-spectrum antibiotic tetracyclines, chlortetracycline, and congeners across more than 190 countries. For each year reported, estimates ...

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Biosimilars and Related Biologics

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Biopharmaceutical
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Hospital Infection Therapeutics

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for hospital infection therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Therapeutics, Research, and Development Epigenetics

  • $ 995
  • November 2019
  • 315 pages

This study covers the world outlook for therapeutics, research, and development epigenetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Contract Research Organizations (CRO)

  • $ 995
  • November 2019
  • 301 pages

This study covers the world outlook for contract research organizations (CRO) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Drug Development
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Systemic Broad- and Medium-Spectrum Antibiotic Erythromycins

  • $ 995
  • November 2019
  • 315 pages

This study covers the world outlook for systemic broad- and medium-spectrum antibiotic erythromycins across more than 190 countries. For each year reported, estimates are given for the latent demand, o ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Novel Drug Delivery Systems (NDDS)

  • $ 995
  • November 2019
  • 301 pages

This study covers the world outlook for novel drug delivery systems (NDDS) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Drug Delivery
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Liver Cancer Therapeutics

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for liver cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Tinea Pedis (Athlete’s Foot) Drugs

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for Tinea Pedis (Athlete’s Foot) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Antifungal
  • OTC
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Hormone Replacement Therapies (HRT)

  • $ 995
  • November 2019
  • 301 pages

This study covers the world outlook for hormone replacement therapies (HRT) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Hormone
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Pharmaceutical Chemicals

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for pharmaceutical chemicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Animal Therapeutics and Diagnostics

  • $ 995
  • November 2019
  • 300 pages

This study covers the world outlook for animal therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Adult Stem Cell Research

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for adult stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Cell Therapy
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Demand

The 2021-2026 World Outlook for Hypertrophic Cardiomyopathy Therapeutics

  • $ 995
  • November 2019
  • 304 pages

This study covers the world outlook for hypertrophic cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2021-2026 World Outlook for Fibromyalgia Therapeutics

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for fibromyalgia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Pharmaceutical
  • Therapy
  • World
  • Demand

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on